Our People

Christopher (Chris) is in our life sciences patent team and has particular experience in the biotechnology, nanotech and pharmaceutical sectors.

His expertise includes:

enzyme technology

diagnostics and prognostic biomarkers

regenerative medicine including differentiation of hES cells into neural cells for use in brain and spinal cord repair

nanomedicine including nanoparticles as drug delivery agent

Alzheimer’s disease biochemistry

Chris has previously provided in-house IP assistance to clients and regularly lectures to clients at seminars.

The Legal 500 (2016) recognises Chris as ‘highly active on the life sciences side‘.

Chris has a degree in Natural Sciences (pharmacology) from Cambridge University and a PhD in Biochemistry from University College London. His PhD project focussed on neurochemistry underlying Alzheimer’s disease. He carried out post-doctoral research on inflammation associated with Alzheimer’s disease.

Chris joined Mewburn Ellis LLP in 2004, qualifying as a Chartered Patent Attorney in 2007 and a European Patent Attorney in 2008. He joined the partnership in 2011.